Oxazine near-infrared fluorescent dye as well as preparation method and application thereof

A fluorescent dye and near-infrared technology, which is applied in the direction of oxazine dyes, organic dyes, luminescent materials, etc., can solve the problem of high non-specific tissue uptake, and achieve the effect of improving specificity and improving specificity

Pending Publication Date: 2022-04-26
CHINA PHARM UNIV
0 Cites 0 Cited by

AI-Extracted Technical Summary

Problems solved by technology

However, all nerve-specific contrast agents...
View more

Abstract

The invention discloses an oxazine near-infrared fluorescent dye as well as a preparation method and application thereof, the oxazine near-infrared fluorescent dye comprises a compound as shown in a formula I, and X is selected from naphthenic bases. The oxazine near-infrared fluorescent dye is targeted to nerves after intravenous injection, shows a relatively high signal background ratio, can realize rapid and long-term nerve visualization, has certain clinical application prospects, and is used for reducing intraoperative nerve injury in a fluorescence-guided surgical operation.

Application Domain

Organic chemistryIn-vivo testing preparations +2

Technology Topic

OxazinesNerve injury +6

Image

  • Oxazine near-infrared fluorescent dye as well as preparation method and application thereof
  • Oxazine near-infrared fluorescent dye as well as preparation method and application thereof
  • Oxazine near-infrared fluorescent dye as well as preparation method and application thereof

Examples

  • Experimental program(5)

Example Embodiment

[0030] Example 1
[0031] Synthesis of YQN-3 (i.e. compound I-1)
[0032] 1. Take 1.50g of m-bromoanisole, 0.73g of cyclopropylamine, 1.36g of potassium tert-butoxide, and 0.05g of tetrakis(triphenylphosphine)palladium in toluene (8ml) and heat to reflux at 80°C for 8h. After the reaction, the solution was spin-dried, and the remaining solid was purified by column chromatography to obtain N-cyclopropyl-3-methoxyaniline as a brown oily liquid. m/z: 164.14.
[0033] 2. Dissolve 200 mg of N-cyclopropyl-3-methoxyaniline in 2M ice-cold dilute hydrochloric acid solution (5 ml), add 103 mg of sodium nitrite into the solution while keeping the solution temperature below 5°C. After the addition, the solution was stirred for another 2 h, then it was dropped into a saturated potassium carbonate solution, extracted with ethyl acetate, the organic layer was dried with anhydrous sodium sulfate, and spin-dried to obtain a yellow-green solid N-cyclopropyl-3-methoxy Base-4-nitrosoaniline. m/z: 192.09.
[0034] 3. At 80°C, dissolve 86 mg of m-hydroxy-N.N-diethylaniline in i-PrOH/H 2 O (9:1, 4ml) for 30min. N-cyclopropyl-3-methoxy-4-nitrosoaniline 100mg and perchloric acid (70%, 47μl) in i-PrOH/H 2 The suspension in O (9:1, 4ml) was added to the above solution. The resulting mixture was then stirred for 8h. During this time, the color of the reaction mixture changed from brown to green and finally dark blue. Then the water in the mixture was removed with anhydrous sodium sulfate, and after being spin-dried, the remaining solid was purified by column chromatography to obtain dark blue solid YQN-3. Its mass spectrometry and H NMR spectrum are as figure 1 As shown, the specific data are as follows: m/z: 308.22, 1H NMR (400MHz, DMSO-d6) δ9.53 (s, 1H), 7.80 (d, J=9.6Hz, 1H), 7.73 (d, J=8.9 Hz, 1H), 7.43(dd, J=9.7, 2.7Hz, 1H), 7.11(d, J=9.1Hz, 1H), 7.04(d, J=2.7Hz, 1H), 6.98(t, J=2.4 Hz, 1H), 3.76(q, J=7.1Hz, 4H), 2.89(tq, J=7.2, 3.6Hz, 1H), 1.26(t, J=7.1Hz, 6H), 0.97(dt, J=6.9 , 3.4Hz, 2H), 0.76-0.64(m, 2H).

Example Embodiment

[0035] Example 2
[0036] Synthesis of YQN-4 (i.e. compound I-2)
[0037] The synthesis of YQN-4 refers to Example 1. Its mass spectrometry and H NMR spectrum are as figure 2 As shown, the specific data are as follows: m/z: 322.21, 1H NMR (400MHz, DMSO-d6) δ9.67 (d, J=6.4Hz, 1H), 7.79 (d, J=9.4Hz, 1H), 7.73 ( d, J=9.3Hz, 1H), 7.46-7.31(m, 1H), 7.15(d, J=9.3Hz, 1H), 6.97(s, 1H), 6.67(s, 1H), 4.43-4.25(m , 1H), 3.74(q, J=7.1Hz, 4H), 2.47(d, J=9.3Hz, 2H), 2.09(p, J=9.6Hz, 2H), 1.84(q, J=8.6Hz, 2H ), 1.25(t, J=7.0Hz, 6H).

Example Embodiment

[0038] Example 3
[0039] Synthesis of YQN-5 (i.e. compound I-3)
[0040] The synthesis of YQN-5 refers to Example 1. Its mass spectrometry and H NMR spectrum are as image 3 As shown, the specific data are as follows: m/z: 336.22, 1H NMR (400MHz, DMSO) δ9.31 (s, 1H), 7.79 (d, J=9.5Hz, 1H), 7.72 (d, J=9.4Hz, 1H), 7.37(d, J=8.6Hz, 1H), 7.17(d, J=10.0Hz, 1H), 7.11-6.96(m, 1H), 6.95(d, J=16.1Hz, 1H), 3.73( dd, J=14.0, 6.9Hz, 4H), 1.95(d, J=9.9Hz, 2H), 1.76(d, J=13.2Hz, 2H), 1.64(d, J=13.7Hz, 1H), 1.36( dt, J=22.3, 11.5Hz, 4H), 1.23(t, J=7.0Hz, 6H).

PUM

no PUM

Description & Claims & Application Information

We can also present the details of the Description, Claims and Application information to help users get a comprehensive understanding of the technical details of the patent, such as background art, summary of invention, brief description of drawings, description of embodiments, and other original content. On the other hand, users can also determine the specific scope of protection of the technology through the list of claims; as well as understand the changes in the life cycle of the technology with the presentation of the patent timeline. Login to view more.

Similar technology patents

Primer pairs, method and fast diagnostic kit for detecting red-spotted grouper nervous necrosis viruses

InactiveCN101591714AReduce background impactImprove specificity
Owner:SOUTH CHINA SEA FISHERIES RES INST CHINESE ACAD OF FISHERY SCI

Tie-2 modulators and methods of use

InactiveUS20070161651A1improve specificity
Owner:EXELIXIS INC

Tie-2 modulators and methods of use

InactiveUS20060293342A1improve specificity
Owner:EXELIXIS INC

Human cytomegalovirus recombinant protein and method for preparing the same

ActiveCN101220085Ahigh specificityStrong immunogenicity
Owner:英诺特(唐山)生物技术有限公司

Kit for detecting pre-S region variation of advanced liver disease related hepatitis B virus

InactiveCN104694665Ahigh specificityStrong sensitivity
Owner:SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY

Classification and recommendation of technical efficacy words

  • Improve specificity
  • high specificity

Primer pairs, method and fast diagnostic kit for detecting red-spotted grouper nervous necrosis viruses

InactiveCN101591714AReduce background impactImprove specificity
Owner:SOUTH CHINA SEA FISHERIES RES INST CHINESE ACAD OF FISHERY SCI

Tie-2 modulators and methods of use

InactiveUS20060293342A1improve specificity
Owner:EXELIXIS INC

Tie-2 modulators and methods of use

InactiveUS20070161651A1improve specificity
Owner:EXELIXIS INC

Applications of the stimulation of neural tissue using light

InactiveUS20060155348A1increase electrical field sizehigh specificity
Owner:DECHARMS RICHARD CHRISTOPHER

Compositions and Methods for Maintenance of Fluid Conducting and Containment Systems

InactiveUS20110027803A1easily and conveniently monitorhigh specificity
Owner:LUX INNOVATE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products